Smith & Nephew (SN.)

 

Latest News

Transaction in Own Shares

RNS Number: 6202W Smith & Nephew Plc 15 November 2017 15 November 2017 Smith & Nephew plc (the "Company") Transaction in Own Shares The Company has today cancelled 309,247 of its Ordinary Shares of US 20 each ("Shares") previously held in Treasury. These shares were issued in connection with employee share schemes in Quarter 2 2017 and have b...

Smith & Nephew says trial shows dressing efficacy

Smith & Nephew said a trial has shown that the addition of its multi-layer polyurethane dressing significantly reduces the...

New RCT demonstrates effectiveness of ALLEVYN LIFE

RNS Number: 4986W Smith & Nephew Plc 15 November 2017 New RCT demonstrates effectiveness of ALLEVYN LIFE to prevent the onset of pressure ulcers 15 November 2017 Smith & Nephew plc (LSE:SN, NYSE:SNN), the global medical technology business, today announces the results of a randomised controlled trial showing that the addition of ALLEVYN L...

Director/PDMR Shareholding

RNS Number: 3664W Smith & Nephew Plc 13 November 2017 SMITH & NEPHEW PLC 13 November 2017 NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSON...

All News

DateHeadlineSource
15-11-17Transaction in Own SharesRNS
15-11-17Smith & Nephew says trial shows dressing efficacyStockMarketWire
15-11-17New RCT demonstrates effectiveness of ALLEVYN LIFERNS
13-11-17Director/PDMR ShareholdingRNS
13-11-17Director Deals - Smith & Nephew PLC (SN.)StockMarketWire
13-11-17Smith & Nephew launches robotics-assisted knee replacement procedureStockMarketWire
13-11-17Launch of robotics-assisted knee replacementRNS
13-11-17Director/PDMR ShareholdingRNS
13-11-17Broker Forecast - JP Morgan Cazenove issues a broker note on Smith & Nephew PLCStockMarketWire
08-11-17Transaction in Own SharesRNS
08-11-17Director/PDMR ShareholdingRNS
07-11-17Transaction in Own SharesRNS
06-11-17Smith & Nephew commences quarterly buy back programmeStockMarketWire
06-11-17Transaction in Own SharesRNS
03-11-17FTSE falls back after mixed economic dataStockMarketWire
03-11-17Director Deals - Smith & Nephew PLC (SN.)StockMarketWire
03-11-17Strong miners lift FTSE 100 StockMarketWire
03-11-17Director/PDMR ShareholdingRNS
03-11-17Smith & Nephew sees FY revenue at low end of guidanceStockMarketWire
03-11-17Trading StatementRNS
02-11-17Director/PDMR ShareholdingRNS
01-11-17Total Voting RightsRNS
01-11-17Director/PDMR ShareholdingRNS
23-10-17FTSE flat despite weaker banksStockMarketWire
23-10-17Smith & Nephew to acquire Rotation MedicalStockMarketWire
23-10-17Acquisition of tissue regeneration technologyRNS
23-10-17Broker Forecast - Deutsche Bank issues a broker note on Smith & Nephew PLCStockMarketWire
20-10-17 Smith & Nephew schedules trading updateStockMarketWire
20-10-17Notice of Results - ClarificationRNS
19-10-17Smith & Nephew confirms details of interim diviStockMarketWire
19-10-17Broker Forecast - JP Morgan Cazenove issues a broker note on Smith & Nephew PLCStockMarketWire
19-10-17Dividend DeclarationRNS
13-10-17Notice of ResultsRNS
11-10-17Sterling suffers on post-Brexit flight warningStockMarketWire
11-10-17FTSE flat as utilities fail to offset underperforming banks StockMarketWire
10-10-17Director/PDMR ShareholdingRNS
09-10-17Strong pound and weak miners punish FTSE StockMarketWire
09-10-17Miners weigh on FTSE StockMarketWire
09-10-17Smith & Nephew CEO to retireStockMarketWire
09-10-17Retirement of Chief Executive Officer by end 2018RNS

RSS feeds

  • Editorial news feed for LSE:SN. Editorial
  • Regulatory news feed for LSE:SN. Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account